Literature DB >> 17657217

Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10.

D Benedetti, R Bomben, M Dal-Bo, D Marconi, A Zucchetto, M Degan, F Forconi, G Del-Poeta, G Gaidano, V Gattei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17657217     DOI： 10.1038/sj.leu.2404867

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia.

Authors:  Dirk Kienle; Axel Benner; Carolin Läufle; Dirk Winkler; Christof Schneider; Andreas Bühler; Thorsten Zenz; Annett Habermann; Ulrich Jäger; Peter Lichter; Riccardo Dalla-Favera; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

2.  ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.

Authors:  Anna Guarini; Marilisa Marinelli; Simona Tavolaro; Emanuele Bellacchio; Monia Magliozzi; Sabina Chiaretti; Maria Stefania De Propris; Nadia Peragine; Simona Santangelo; Francesca Paoloni; Mauro Nanni; Ilaria Del Giudice; Francesca Romana Mauro; Isabella Torrente; Robin Foà
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.